Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1

OBJECTIVE: It remains unclear whether human T-cell leukemia virus type 1 (HTLV-1) infection influences therapeutic responses in patients with rheumatic diseases and whether immunosuppressive treatments increase the risk of HTLV-1-related complications in HTLV-1 carriers with rheumatic diseases. We e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Int Med Res
Hlavní autoři: Endo, Yushiro, Fukui, Shoichi, Koga, Tomohiro, Sasaki, Daisuke, Hasegawa, Hiroo, Yanagihara, Katsunori, Okayama, Akihiko, Nakamura, Tatsufumi, Kawakami, Atsushi, Nakamura, Hideki
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2021
Témata:
Pre-Clinical Research Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7989142/
https://ncbi.nlm.nih.gov/pubmed/33745335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/03000605211002083
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky